Charles and Jane Pak Center for Mineral Metabolism and Clinical Research

Medicine & Life Sciences

1. Kidney 100%
2. Diabetic Foot 60%
3. Chronic Renal Insufficiency 45%
4. Blood Pressure 45%
5. Phosphates 45%
6. Acute Kidney Injury 41%
7. Bone and Bones 40%
8. fibroblast growth factor 23 38%
9. Kidney Calculi 37%
10. Osteomyelitis 36%
11. Kidney Diseases 33%
12. Hypertension 32%
13. Citric Acid 32%
14. Infections 31%
15. Urine 27%
16. Foot 27%
17. Biomarkers 25%
18. Uric Acid 25%
19. Serum 25%
20. Nephrolithiasis 24%
21. Precision Medicine 23%
22. Critical Illness 23%
23. Muscles 22%
24. Minerals 21%
25. Osteoblasts 19%
26. Autophagy 19%
27. Exercise 19%
28. Fibrosis 18%
29. klotho protein 18%
30. Nephrology 18%
31. Alkalies 17%
32. Therapeutics 17%
33. Urinary Calculi 17%
34. Acids 17%
35. Heart 17%
36. Health 17%
37. Skeletal Muscle 16%
38. Beclin-1 16%
39. Soft Tissue Infections 16%
40. Familial Hypophosphatemia 15%
41. Calcium Oxalate 15%
42. Bone Density 15%
43. Creatinine 15%
44. calcium phosphate 14%
45. Sodium Chloride Symporter Inhibitors 14%
46. Stents 13%
47. Guidelines 13%
48. Medication Adherence 13%
49. Ureteroscopy 13%
50. Glutamine 12%
51. Oxalates 12%
52. Cohort Studies 12%
53. Chronic Kidney Disease-Mineral and Bone Disorder 12%
54. Spinal Ganglia 12%
55. Proteins 11%
56. Antihypertensive Agents 11%
57. Osteoporosis 11%
58. Wounds and Injuries 11%
59. Biopsy 11%
60. Hypophosphatemia 11%
61. Negative-Pressure Wound Therapy 11%
62. Magnesium 10%
63. Reflex 10%
64. Cellular Senescence 10%
65. Obesity 10%
66. Proline 10%
67. Cardiovascular Diseases 10%
68. Positron-Emission Tomography 9%
69. Pharmacology 9%
70. Diet 9%
71. Blood Sedimentation 9%
72. Fats 9%
73. Glomerular Filtration Rate 9%
74. Arteriovenous Fistula 9%
75. Chlorthalidone 9%
76. Inbred SHR Rats 9%
77. Calcium 9%
78. Metabolic Bone Diseases 8%
79. Adiponectin 8%
80. Denervation 8%
81. Amino Acids 8%
82. Type 2 Diabetes Mellitus 8%
83. Clinical Trials 8%
84. Fatty Acids 8%
85. Bone Diseases 8%
86. Copper-67 8%
87. Dementia 8%
88. Hypercalcemia 8%
89. Parathyroid Hormone 8%
90. potassium-magnesium citrate 8%
91. Magnetic Resonance Imaging 8%
92. Insulin Resistance 8%
93. Amputation 8%
94. Cystic Fibrosis 7%
95. Hydroxymethylglutaryl-CoA Reductase Inhibitors 7%
96. Hyperglycemia 7%
97. Hypercalciuria 7%
98. romosozumab 7%
99. Noise 7%
100. Aromatase deficiency 7%